Cipla Q3 FY2023 Investor Presentation January 2023

Cipla's Q3 FY2023 investor presentation highlights strong revenue growth of 6% reported YoY (11% ex-covid), driven by robust performance in One-India and US differentiated portfolios. The company achieved INR 5,810 Cr in overall revenue with 24.2% EBITDA margin, with continued strength in respiratory products, biosimilars, and international markets.